Preserflo TM MicroShunt implantation combined with Ologen TM in primary and secondary glaucoma patients in a clinical setting.

However, there was a tendency for performing cataract surgery and having an IOP of >8 mmHg on postoperative day 1 to reduce the probability of success (odds ratio = 0.18; P = 0.0513 and odds ratio = 0.123; P = 0.0682, respectively), although these did not reach statistical significance [ Table 3 ].

also in 111,027 other papers